These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12837587)

  • 1. Voice dysfunction in dysarthria: application of the Multi-Dimensional Voice Program.
    Kent RD; Vorperian HK; Kent JF; Duffy JR
    J Commun Disord; 2003; 36(4):281-306. PubMed ID: 12837587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acoustic analysis for 21 patients with amyotrophic lateral sclerosis complaining of dysarthria].
    Xie HS; Ma FR; Fan DS; Wang LP; Yan Y; Lu PQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):751-5. PubMed ID: 25331399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
    Dias AE; Limongi JC
    Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acoustic analysis of voice in individuals with amyotrophic lateral sclerosis and perceptually normal vocal quality.
    Silbergleit AK; Johnson AF; Jacobson BH
    J Voice; 1997 Jun; 11(2):222-31. PubMed ID: 9181546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
    Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
    Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acoustic analysis of voice in bulbar amyotrophic lateral sclerosis: a systematic review and meta-analysis of studies.
    Chiaramonte R; Bonfiglio M
    Logoped Phoniatr Vocol; 2020 Dec; 45(4):151-163. PubMed ID: 31760837
    [No Abstract]   [Full Text] [Related]  

  • 7. Cepstral analysis of hypokinetic and ataxic voices: correlations with perceptual and other acoustic measures.
    Jannetts S; Lowit A
    J Voice; 2014 Nov; 28(6):673-80. PubMed ID: 24836365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F
    Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential phonatory characteristics of four women with amyotrophic lateral sclerosis.
    Strand EA; Buder EH; Yorkston KM; Ramig LO
    J Voice; 1994 Dec; 8(4):327-39. PubMed ID: 7858668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal acoustic measures of dysarthria associated with amyotrophic lateral sclerosis.
    Caruso AJ; Burton EK
    J Speech Hear Res; 1987 Mar; 30(1):80-7. PubMed ID: 3560901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acoustic voice analysis: reliability of a set of multi-dimensional parameters].
    González J; Cervera T; Miralles JL
    Acta Otorrinolaringol Esp; 2002 Apr; 53(4):256-68. PubMed ID: 12185903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
    Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
    Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acoustic analysis of the tremulous voice: assessing the utility of the correlation dimension and perturbation parameters.
    Shao J; MacCallum JK; Zhang Y; Sprecher A; Jiang JJ
    J Commun Disord; 2010; 43(1):35-44. PubMed ID: 19909966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acoustic investigation of vocal quality following treatment for childhood cerebellar tumour.
    Cornwell PL; Murdoch BE; Ward EC; Kellie S
    Folia Phoniatr Logop; 2004; 56(2):93-107. PubMed ID: 15001825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between Subjective and Objective Assessment of Speech Deficiency in Parkinson Disease.
    Pawlukowska W; Szylińska A; Kotlęga D; Rotter I; Nowacki P
    J Voice; 2018 Nov; 32(6):715-722. PubMed ID: 29122413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vocal acoustic characteristics of patients with Parkinson's disease.
    Tanaka Y; Nishio M; Niimi S
    Folia Phoniatr Logop; 2011; 63(5):223-30. PubMed ID: 21212679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses.
    Hlavnička J; Tykalová T; Ulmanová O; Dušek P; Horáková D; Růžička E; Klempíř J; Rusz J
    Clin Neurophysiol; 2020 May; 131(5):1155-1165. PubMed ID: 32146096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parkinsonian dysarthria].
    Gentil M; Pollak P; Perret J
    Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.